MIR1303: A Potential Drug Target and Biomarker (G100302284)
MIR1303: A Potential Drug Target and Biomarker
MIR1303 is a protein that is expressed in various tissues of the body, including the brain, lungs, and gastrointestinal tract. It is a heat shock protein (HSP) that is known for its ability to withstand high temperatures and to protect cells from thermal stress. MIR1303 has been shown to play a role in a variety of biological processes, including cell survival, DNA damage repair, and inflammation.
One of the potential benefits of MIR1303 as a drug target is its ability to modulate the expression of genes in cancer cells. Studies have shown that MIR1303 can be downregulated in cancer cells, which can lead to the activation of genes that promote cell growth and survival. By targeting these genes, MIR1303 could be used to treat a variety of cancers, including breast, lung, and ovarian cancers.
In addition to its potential as a drug target, MIR1303 has also been shown to be a potential biomarker for cancer. Studies have shown that MIR1303 can be expressed in various types of cancer, and that its expression levels can be used as a predictor of cancer outcomes, such as disease progression and response to treatment. This makes MIR1303 an attractive candidate for use as a biomarker for cancer diagnosis and treatment.
Another potential benefit of MIR1303 as a drug target is its ability to modulate inflammation. Chronic inflammation is a major risk factor for a variety of diseases, including heart disease and autoimmune disorders. MIR1303 has been shown to play a role in the regulation of inflammatory responses, and could be used to treat a variety of inflammatory disorders.
In conclusion, MIR1303 is a protein that has the potential to be a drug target and biomarker for a variety of diseases. Its ability to modulate the expression of genes in cancer cells, as well as its potential as a biomarker for cancer diagnosis and treatment, makes it an attractive candidate for further research.
Protein Name: MicroRNA 1303
The "MIR1303 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1303 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR1304 | MIR1305 | MIR1306 | MIR1307 | MIR130A | MIR130B | MIR132 | MIR1321 | MIR1322 | MIR1323 | MIR1324 | MIR133A1 | MIR133A1HG | MIR133A2 | MIR133B | MIR134 | MIR1343 | MIR135A1 | MIR135A2 | MIR135B | MIR136 | MIR137 | MIR137HG | MIR138-1 | MIR138-2 | MIR139 | MIR140 | MIR141 | MIR142 | MIR143 | MIR144 | MIR145 | MIR1468 | MIR1469 | MIR146A | MIR146B | MIR1470 | MIR1471 | MIR147A | MIR147B | MIR148A | MIR148B | MIR149 | MIR150 | MIR151A | MIR151B | MIR152 | MIR153-1 | MIR153-2 | MIR1537 | MIR1538 | MIR1539 | MIR154 | MIR155 | MIR155HG | MIR1587 | MIR15A | MIR15B | MIR16-1 | MIR16-2 | MIR17 | MIR17HG | MIR181A1 | MIR181A1HG | MIR181A2 | MIR181A2HG | MIR181B1 | MIR181B2 | MIR181C | MIR181D | MIR182 | MIR1825 | MIR1827 | MIR183 | MIR184 | MIR185 | MIR186 | MIR187 | MIR188 | MIR18A | MIR18B | MIR1908 | MIR1909 | MIR190A | MIR190B | MIR191 | MIR1910 | MIR1911 | MIR1912 | MIR1913 | MIR1914 | MIR1915 | MIR1915HG | MIR192 | MIR193A | MIR193B | MIR193BHG | MIR194-1 | MIR194-2 | MIR194-2HG
